|

Pelvic Cancer Registry for Online Adapted Radiotherapy

RECRUITINGSponsored by University Medical Center Goettingen
Actively Recruiting
SponsorUniversity Medical Center Goettingen
Started2024-01-01
Est. completion2029-09
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06185062

Summary

This prospective registry-based trial will include patients with pelvic or thoracic tumors with an indication for radiotherapy treated with oART or IGRT. For the primary endpoint and the secondary clinical endpoints, the trial will compare oART versus IGRT, for technical endpoints the trial will compare the real oART scenario with two virtual (hypothetical) control scenarios. Primary endpoint: * 10% reduction in the rate of acute radiotherapy related toxicity (≥ CTCAE II°, v5.0) using oART Secondary endpoints: * Clinical endpoints: Tumor control, late toxicities compared to conventional irradiated patients, quality of life and patient-reported outcomes * Technical endpoints: Target volume, target coverage, dose to organs at risk, anatomical variability score

Eligibility

Age: 18 Years+Healthy volunteers accepted
INCLUSION CRITERIA

* Patients with pelvic or thoracic tumors with an indication for radiotherapy
* Patient information and declaration of consent
* Patients age ≥ 18 years

EXCLUSION CRITERIA

* Prior radiotherapy in affected site

Conditions3

CancerPelvic TumorThoracic Tumor

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.